ORACLE - Randomized Phase 3 Study evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) compared to Investigator’s Choice Therapy in Patient with Relapsed or Refractory Angioimmunoblastic T cell Lymphoma (ORACLE)”,

  • Craddock, Charles (Principal Investigator)

Project Details

Short titleORACLE - Randomized Phase 3 Study evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) compared to Investigator’s Choice Therapy in Patient with Relapsed or Refractory Angioimmunoblastic T cell Lymphoma (ORACLE)”,
StatusActive
Effective start/end date1/08/19 → 31/12/24

Funding

  • The Lymphoma Academic Research Organisation